US Patent Issued to UCB BIOPHARMA on July 7 for "Bispecific antibodies against CD9 and CD7" (British Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,992, issued on July 7, was assigned to UCB BIOPHARMA SRL (Brussels).

"Bispecific antibodies against CD9 and CD7" was invented by David Alan Cook (Slough, Great Britain), Helen Margaret Finney (Slough, Great Britain) and Stephen Edward Rapecki (Slough, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to multispecific antibodies against a novel targets' combination of CD7 and CD9, and their use in the treatment of cancer and infectious diseases."

The patent was filed on Feb. 13, 2020, under Application No. 17/929,029.

*For further information, including images, charts and tables, please visit: http://patft.us...